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Experimental allergic encephalomyelitis (EAE),' is an autoimmune paralytic
and inflammatory disease of the central nervous system (CNS) induced by the
injection, in CFA, of heterologous myelin basic protein (MBP) or whole brain
homogenate. It is one of the principal animal models for human CNS inflam-
matory and demyelinating disorders such as multiple sclerosis (MS); both diseases
are characterized by considerable infiltration of leukocytes into the CNS, whose
phenotypes have been extensively documented in the rat (1), mouse (2), guinea
pig (3), and in brain tissue from MS patients (4).
While there is now little doubt that EAE after MBP injection has a cellular
pathogenesis and that its induction is dependent on the presence of functioning
T cells of the helper/inducer (CD4+) lineage (5-8), it is not yet known how these
cells induce disease. Moreover, the use of defined CD4' encephalitogenic T cell
lines and clones in both mice (7) and rats (8), while greatly increasing our
understanding of some aspects of this disease, in particular the means by which
self antigen may be presented to such autoreactive cells, has not significantly
furthered our understanding of the actual mechanisms of damage in the CNS.
The accumulation ofa considerable cellular infiltrate in the CNS ofanimals with
EAE, whether induced with T cell lines (7, 8) or via conventional means after
injection of MBP and adjuvant or transfer of cells from actively immunized
animals (9, 10), has been taken as evidence that EAE may be the clinical
manifestation of a delayed-type hypersensitivity (DTH) reaction in the CNS. All
that can be saidwith confidence, however, is thatappropriate MBP-specific CD4+
cells, when injected into recipient rats or mice, are sufficient to induce both
clinical signs and classic histological evidence of EAE (i.e., perivascular leukocyte
infiltration reminiscent ofa DTH reaction), but exactly which ofthe infiltrating
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cells, whether acting alone or in collaboration with others, is essential for
pathogenesis has not yet been established .
Herein, evidence isproduced that severely weakens the link between EAE and
DTH . As we now show in the rat, EAE may be mediated by a small number of
CD4+ IL-2-R' encephalitogenic cells that act in the virtual absence of other
infiltrating leukocytes to induce clinical signs of EAE, possibly by producing
vascular damage .
Materials and Methods
Animals .
￿
Specific pathogen-free male or female Lewis (RT 1') rats, 8-12 wk old, were
used in all experiments . Rats were obtained from the animal breeding unit of the MRC
Cellular Immunology Unit, Oxford .
In Vitro Stimulation ofEAE Effector Cells.
￿
MBP-reactive cells for adoptive transfer to
recipient animals were from rats injected subcutaneously in the hind footpads with 50,ug
MBP, prepared as described previously (5) emulsified in CFA . 12-15 d later, when the
majority of animals displayed clinical signs of disease (limp tail or hind limb paresis),
splenocytes were prepared from these animals and cultured in the presence ofMBP for 3
d as previously described (11) . Control (OVA-reactive) cells for transfer to recipient
animals were generated essentially as described above except that the donor Lewis rats
were injected with 100 lAg OVA (Sigma Chemical Co ., St . Louis, MO) in CFA . Spleens
were removed 15 d later and splenocytes were cultured in the presence of 20,ug/ml OVA .
Passive Transfer ofEAE .
￿
Recipient animals were either treated with cytotoxic drugs or
gamma radiation (see below) or left untreated, before receiving between 4 and 6 x 10'
viable, 3-d cultured splenocytes intravenously . The animals were subsequently observed
for clinical signs of disease over the ensuing 2 wk and culled for histological examination
of the CNS where appropriate .
Treatment ofRecipientAnimals.
￿
Removal of the majority of leukocytes in recipient rats
was effected in two ways . Both protocols induced considerable leukopenia (peripheral
blood leukocyte count equal to 3-6% of untreated rats) when measured 5-7 d after
treatment .
Irradiation. Rats received 600 Rad on two occasions, 3 d before cell transfer and
again, 4 h before receiving cultured cells (' s'CS, 88 rad/min ; Gamma Cell 40) .
Cytotoxic Drugs .
￿
The regimen of drugs for the removal of leukocytes and platelets in
the rat was a slight modification of that described elsewhere (12, 13). 3 d before receiving
cultured cells, animals were administered 20 mg/kg busulfan (Sigma Chemical Co .) . The
drug was first dissolved in DMSO then diluted to 10% in olive oil and 1 ml was injected
intraperitoneally . 24 h later, animals received 12 mg/kg chlorambucil (Sigma Chemical
Co .) . This drug was resuspended in olive oil and 0.5 ml of the suspension was also injected
intraperitoneally .
Assessment of Clinical Signs ofEAE .
￿
Signs ofEAE were assigned an arbitrary scale of
severity as follows : -, no signs ; 1, limp tail ; 2, hind limb paresis ; 3 and 4, unilateral and
bilateral hind limb paralysis, respectively ; 5, bilateral hind limb paralysis with incontinence
and/or more severe signs .
Histological Examination ofRecipient Rats .
￿
Paraffin or cryostat sections were prepared
from the spinal cord, brain stem, cerebrum (all coronal sections), and cerebellum (para-
sagittal sections) of recipient animals . Paraffin sections (7 gym) were stained with H and E,
while cryostat sections (5 gm) were stained for cell surface antigens using a variety of
mAbs (see below) in combination with the immunoperoxidase method (14) using a
peroxidase-conjugated rabbit anti-mouse Ig as second antibody (Dako Corp ., Santa
Barbara, CA) . Where staining was weak, enhancement of the brown diaminobenzidine
substrate product was effected via a silver intensification procedure as described in detail
elsewhere (15) . All cryostat sections were lightly counterstained with hematoxylin .
Monoclonal Antibodies.
￿
mAbs used in these investigations were as follows : MRC OX-1
and MRC OX-30, noncompetitive antibodies that recognize the leukocyte-common anti-1060
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gen (L-CA, reference 16); MRC OX-6, which recognizes a nonpolymorphic determinant
on rat la, MHC class II antigen (17); MRC OX-8, which recognizes cytotoxic/suppressor
T cells and NK cells (CD8, reference 18); MRC OX-19, which recognizes T cells and
thymocytes (CD5, reference 18); MRC OX-21, which recognizes human C3b inactivator
but not rat cells (19); MRC OX-39, which recognizes the IL-2-R (see Results); MRC 0X-
42, which recognizes macrophages and microglia via the iC3b receptor (20); MRC 0X-
52, which recognizes all T cells and thymocytes but is noncompetitive with MRC OX-19
(not CD5, reference 21); and W3/25, which recognizes T helper/inducer cells and
macrophages (CD4, references 18 and 22).
Leukocytes were detected with a mixture of the mAbs MRC OX-1 and MRC OX-30
while T cells were stained with a combination of mAbs, MRC OX-19 and MRC OX-52.
Tissue culture supernatants diluted one-third were used throughout.
Delayed-type Hypersensitivity.
￿
DTH responses in irradiated and nonirradiated animals
receiving MBP or OVA reactive cells were tested as follows: 2 d after receiving in vitro-
stimulated splenocytes, each animal was injected subcutaneously in one ear with 20 jug
MBP in 20 IA1 PBS and, in the contralateral ear, with 40 pig OVA in 20 tsl PBS (i.e.,
equimolar concentrations of antigen). 24 h later, the thickness of each ear was measured
in triplicate using a Quicktester Micrometer gauge (H. C. Kroplin, Federal Republic of
Germany) and a mean score for each ear was determined. Measurements were performed
by an operator unfamiliar with the immunological status of the animals. After ear
measurement, some animals were culled and ears were removed for histological exami-
nation. All remaining animals were assessed for clinical signs of EAE over the following
7-10 d.
Results
Severe Clinical Signs of EAE in Rats with a Minimal Leukocyte Infiltrate in the
CNS. Our recent investigations in this laboratory designed to establish the host
contribution to passive EAE noted that severe paralytic disease could be induced
in recipient animals that had received lethal doses of irradiation before cell
transfer. This finding was investigated further by an analysis of the cells infil-
trating the CNS in both irradiated and nonirradiated recipients, using mAbs that
recognize a range of cell- and tissue-specific antigens (see Materials and Methods).
Of particular note here is MRC OX-39, which recognizes the rat 11-2-R. The
specificity of this recently developed mAb has been defined by its ability to bind
to activated, but not resting T cellsand by its inhibitionof binding ofradiolabeled
IL-2 to such activated cells. The antibody precipitates, from rat T blasts, a
protein of 45-50 kD, similar in molecular mass to that of mouse (23) and human
(24) IL-2-R (Jefferies, W. A ., D . J. Paterson, P. Cortese, J. R. Green, M . Puklavec,
and A . F. Williams, manuscript in preparation).
Lewis rats were injected with either MBP or OVA in adjuvant and their
splenocytes were subsequently stimulated in vitro with the same antigen before
transfer to either normal or irradiated recipient animals (Table I). 5-7 d after
cell transfer when recipient animals exhibited signs of disease (or on day 7 in the
case of recipients of OVA-reactive cells that never displayed any clinical signs),
the animals were culled, brain and spinal cords were removed, and cryostat
sections were assessed for infiltrating cells. In these studies, examination of spinal
cord material extending from the cervical to cauda equina regions did not reveal
any significant differences in the degree of cellular infiltration, and hence the
data reported in Table I are those obtained only from material recovered from
the thoracic cord.
It is clear from Table I that regardless of the status of the recipient (irradiatedSEDGWICK ET AL .
￿
106 1
TABLE I
Analysis ofInfiltrating Cells in the Spinal Cord ofRats with PassiveEAE
Figures shown are the number of nucleated cells recognized by mAbs against these cell markers in 10 random fields under x 800
magnification (a total area of0.13 mms). Animals in groups A and B received MBP-reactive splenocytes while those in groups C and
D received OVA-stimulated splenocytes. Animals in groups E and F did not receive cells . Sections stained with the control mAb MRC
OX-21 were uniformly negative (data not shown).
or not), clinical signs were induced when the animals received MBP-reactive
cells . The similarity between the two groups ends here, however, as there is a
clear disparity between the number of leukocytes detected in the spinal cords of
these animals (see also Fig . 1) . As expected, spinal cords of nonirradiated
recipients were infiltrated by large numbers of leukocytes, many of which were
class II MHC antigen la'. Both CD4' andCD8+ cells were also present, although
the majority of the CD4' cells had the appearance of macrophages rather than
lymphocytes, a finding supported by the observation that fewer cells were
recognized by T cell-specific (pan T) mAbs than were detected by anti-CD4
mAbs alone (see Table I) . MRC OX-42 antibody which, like Mac 1 in the mouse
(25), recognizes macrophages and microglia, also labeled a considerable number
of cells in the spinal cords of these animals . The increase above control values
(groups D and F) was not as great as with other markers, however, as this
antibody labeled microglia that were of course present in normal (non-EAE)
animals . Infiltrating leukocytes, many of which were perivascular, were mainly
clustered in discrete areas in the white matter (see Fig . 1, a and b) .
In stark contrast to this typical picture of EAE, irradiated recipients (group A)
contained markedly reduced numbers of infiltrating leukocytes and, as Fig . 1 c
shows, there were no inflammatory foci . The few positively staining cells were
Group Treatmentof recipient Animal
Disease stage
when culled
for histology
class
11
Cells/0 .18
L-CA
mm2 in
Pan T
thespinal
CD4
cord
CDS
positive for:
IL-2-R
MRC
0X-42
A Irradiated plus MBP-acti- 1 5 5 10 ND 5 1 ND 18
vated cells 2 5 3 8 7 10 2 4 18
3 5 3 11 8 6 1 7 7
4 5 4 7 7 4 1 6 11
5 5 5 10 5 7 0 6 24
6 4 3 11 7 4 2 5 6
B No irradiation plus MBP- 1 4 200 190 ND 79 19 ND 104
activated cells 2 4 194 216 ND 120 33 ND 184
3 2 107 81 47 76 31 7 80
4 5 106 78 34 51 14 7 85
5 2 115 86 37 66 12 6 88
6 4 135 122 51 73 19 6 86
C Irradiated plus OVA-acti- 1 - 0 2 1 1 0 0 8
vated cells 2 - 0 1 0 3 0 0 7
D No irradiation plus OVA- I - 1 I 0 2 0 0 13
activated cells 2 - 0 2 0 1 0 1 10
E Irradiated only 1 - 0 2 1 0 0 ND 5
2 - 0 1 0 1 0 ND 7
3 - 0 1 0 0 0 0 6
4 - 0 0 0 3 0 0 10
F No treatment 1 - 2 1 ND 1 0 ND 12
2 - 1 0 ND 4 0 ND 10
3 - 0 2 0 2 0 0 131062
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FIGURE 1 .
￿
Microscopic appearance of spinal cord from irradiated recipient rats . Shown are
sections of spinal cord from rats 5-7 d after receiving MBP- or OVA-stimulated splenocytes .
(a, c, and e) Cryostat sections stained for leukocytes by using mAbs MRC OX-1 andMRC0X-
30 (see Materials and Methods) ; (b, d andf ) paraffin sections stained with H and E. (a and b)
Nonirradiated recipients of MBP-reactive cells (X 160) ; (c and d) irradiated recipients of MBP-
reactive cells (X 100 and X 130, respectively) ; (e andf) irradiated recipients ofOVA-reactive
cells (X 130) . (c and d) Arrows designate areas of hemorrhage. Spinal cord in a-d is from
animals with severe clinical signs of EAE (at least unilateral hind limb paralysis), while that in
e andf is from animals with no signs of disease .
distributed throughout the white and, to a lesser extent, the grey matter of the
spinal cord . The association of these cells with structural elements in the CNS,
in particular the vasculature, was difficult to establish with the single stainingSEDGWICK ET AL .
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FIGURE 2 .
￿
IL-2-R' cells infiltrating the spinal cord of irradiated andnonirradiated recipient
animals with EAE. Shown are cryostat sections of thoracic spinal cord from nonirradiated (a
and b) and irradiated (c and d) rats 5-7 d after receiving MBP-stimulated splenocytes . The
sections are stained forT cells (a and c) andfor the IL-2-R (b and d) . Arrows indicate IL-2-R'
cells . X 410 .
procedure used here . Dual staining of infiltrating lymphocytes and the vascula-
ture, the latter with an mAb that exclusively labels the vascular endothelium in
the rat brain (26), should help resolve this uncertainty.
This reduction in leukocyte infiltration in irradiated recipients was reflected
in the numbers of cells reactive with all but one of the mAbs used to define the
phenotypes of the cells present in the spinal cords of these animals . The notable
exception was that the numbers of IL-2-R' cells were very similar in irradiated
and nonirradiated recipients of MBP-reactive cells. Thus, while there was a
considerableT cell infiltrate in nonirradiated recipient animals, relatively few of
these expressed the IL-2-R as illustrated in the serial sections of Fig. 2, a and b .
In contrast, the spinal cord of irradiated recipients contained only low numbers1064
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of infiltrating T lymphocytes (Fig . 2c) and cells expressing the IL-2-R were
present at about the same frequency (Fig . 2d and Table I, group A) .
It should be noted that the features summarized in Table I are not character-
istic solely of the spinal cord of these animals. Comparable investigations of the
brainstem andcerebellum ofboth irradiatedand nonirradiated recipient animals
revealed similar patterns of infiltrating leukocytes to those seen in the spinal
cord, although in general, cerebellar leukocyte infiltrate tended to be less than
that seen in the spinal cord and brain stem ; cerebral leukocyte infiltrate was
virtually absent (data not shown) .
Hemorrhage in the CNS ofIrradiated Rats with Passive EAE .
￿
Both the macro-
scopic and microscopic appearance of the spinal cord in irradiated recipient
animals of MBP-reactive cells differed markedly from that seen in nonirradiated
rats . In the latter group, the macroscopic appearance of the spinal cord was
unremarkable while at the microscopic level the only visible pathology was the
considerable, predominantly perivascular leukocyte infiltrate described in the
previous section. In irradiated recipients of MBP-reactive cells, however, at the
macroscopic level the surface of the spinal cord was considerably altered from
normal, with multiple areas of hemorrhage . At the microscopic level these areas
were also observed in cryostat sections extending inward from the surface of the
cord (Fig . 1 c, arrow) . As expected from the presence of hemoglobin they were
weakly stained nonspecifically by the immunoperoxidase process . Subsequent
examination of spinal cord stained with H and E confirmed the presence of
erythrocytes in the white and grey matter of spinal cord of only those irradiated
animals that received MBP-reactive cells (Fig . 1 d) . Spinal cord from irradiated
recipients of OVA-reactive cells (Fig. 1, e andf), like nonirradiated recipients of
MBP-reactive cells (the latter with both clinical signs and considerable cellular
infiltrate, Fig . 1 b), did not show any hemorrhagic lesions at either the macro-
scopic or microscopic level . Spinal cord from nonirradiated recipients of OVA-
reactive cells (not shown) was identical in appearance to that of their irradiated
counterparts (Fig . 1, e andf ) .
Other CNS tissues in irradiated recipients of MBP-reactive cells were also
examined (data not shown) . Areas of white matter hemorrhage were present in
the brain stem, although to a lesser extent than that seen in the spinal cord .
Scattered erythrocytes were occasionally observed in the parenchyma of the
cerebellar white matter of these animals while hemorrhage was absent in the
cerebrum .
Effect of Injected Anti-CD4 mAb on Clinical and Histological Signs of EAE in
Irradiated Recipients . Recent studies in this laboratory have established that
both actively (5) and passively (11) induced EAE in the rat can be prevented by
the in vivo administration of the mouse W3/25mAb against the ratCD4 antigen .
To assess whether passively transferred EAE in irradiated animals was similarly
susceptible to this form of treatment, irradiated or nonirradiated recipient rats
were injected intravenously with either anti-CD4 (W3/25) IgG or the control
mAb MRC OX-21 for seven consecutive d after transfer of MBP-stimulated
splenocytes (for details see legend to Table II and reference 11) . The animals
were assessed for clinical signs of EAE during and after mAb treatment andGroup
￿
Treatment ofrecipients
B
￿
Irradiated plus MBP activated
cells day 0 plus MRC OX-21
mAb day 0-6 inclusive
C
￿
Not irradiated plus MBP acti-
vated cells day 0 plusanti-
CD4 IgG day 0-6 inclusive
D
￿
Not irradiated plus MBP acti-
vated cellsday 0 plus MRC
OX-21 mAb day 0-6 inclu-
sive
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TABLE 11
Anti-Rat CD4 mAb Prevents ClinicalEAE and Hemorrhage in Irradiated RecipientAnimals
A
￿
Irradiated plus MBP-activated
cells day 0 plus anti-CD4 IgG
day 0-6 inclusive
Irradiated or nonirradiated rats received MBP-reactive cells on day 0 and either 0 .3 mg sterileW3/25 (anti-CD4) IgG or 0.5 ml sterile MRC
OX-21 ascites (ascites diluted to -0 .6 mg specific antibody per milliliter) intravenously on days 0-6 (inclusive) . Animals were assessed for
clinical signs of EAEand some from each group subsequently culled for histological examination ofthe CNS .
* Leukocyte infiltrate is that observed in cryostat sections of the spinal cord, brain stem, and cerebellum stained for the L-CA. (-) None
observed ; (+/-) minimal infiltrate, no perivascular cuffing (see Table 1, group A); +++, extensive perivascular and parenchymal infiltrate.
# Refers tothe presence (+) or absence (-) ofhemorrhage in the spinal cord and brain stem of these animals . Rats I and 2 in group A and rat
2 in groups B, C, and D were assessed for hemorrhage only at the macroscopic level . Rats 3 and 4 in each group were examined for
hemorrhage at both the macroscopicand microscopic level, the latter by staining of paraffin sections with H and E .
Sampled for histological examination .
subsequently culledand examined for the presence of infiltrating leukocytes and
hemorrhage in theCNS (Table II) .
Animals treated with anti-CM mAb, whether irradiated (group A) or not
(group C), did not show any clinical signs of EAE, in contrast to those receiving
the control mAb, MRC OX-21 (groups B and D) . Of those irradiated animals
treated with anti-CM mAb that were not culled for histology in this (group A,
rats 1 and 2) and other comparable experiments, no disease was observed up to
10-12 d after cell transfer, at which time the rats died, presumably as a direct
result of the lethal dose of irradiation they had received . Furthermore, of
particular interest was the complete absence of hemorrhagic lesions in irradiated
recipients receiving anti-CM mAb (group A) .
Those irradiated animals receiving control mAb (group B) typically showed
signs of EAE 5-7 d after receiving cultured cells, and they showed hemorrhage
in both the spinal cord and brain stem . There was no indication of hemorrhage
at either the macroscopic or microscopic level in nonirradiated recipient rats
(groups C and D) .
The extent of leukocyte infiltrate was variable . In keeping with previous
observations, irradiated animals receiving control mAbs (group B) had only a
minimal infiltration of leukocytes into the spinal cord, brain stem, and cerebel-
lum, while there was extensive perivascular cuffing in similarly treated nonirra-
diated recipient rats (group D) . As has been observed in earlier studies (11), anti-
CM mAb treatment of nonirradiated recipient rats (group C) resulted in a
Animal
0 1
Clinical score (days after cell transfer)
2 3 ,4 5 6 7 8 9 10
Leuko-
cyte in-
filtrate*
Hemor-
rhagex
I - - - - - - - - - - Dead ND
2 - - - - - - - - - - Dead ND
3 - - - - - - - -1 -
4 _ _ _ _ _ _ - -li _
I - 1 2 Dead ND ND
2 - 1 1 3f ND +
3 - 1 41 +/- +
4 1 1 51 +/- +
I ND ND
2 _ _i ND
3
4
1 1 3 5 1 1 ND ND
2 - 2 5 2 1 ND
3 1 411
4 1 4111066
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FIGURE 3 .
￿
Hemorrhage in the spinal cord of leukopenic recipient rats after treatment with
cytotoxic drugs . Recipient rats were treated with a combination of two cytotoxic drugs (see
Materials and Methods), and some were then injected with MBP-reactive splenocytes. 5-7 d
later, at a time when the cell recipients showed signs of EAE (at least limp tail), all animals
were culled for histological examination . Shown are paraffin sections of spinal cord stained
with H and E from animals that received MBP-stimulated cells (a, x 100) or did not (b, x
100) . Areas of hemorrhage are indicated by arrows .
substantial reduction in the numbers of cells infiltrating the CNS, and hence it
was not surprising that the spinal cord, brain stem, and cerebellum in irradiated
recipient animals receiving anti-CD4 mAbs, were completely devoid of infiltrat-
ing leukocytes (group A) .
Hemorrhage Is Not an Irradiation Artefact .
￿
Given the appearance of hemor-
rhage only in those rats that received MBP-reactive cells (Fig . 1) and its preven-
tion by anti-CD4 mAb (Table 11, group A), it was considered highly unlikely that
the observed hemorrhage was artefactual, but rather, the visible signs of specific
damage to the vasculature by the injected MBP-reactive, CD4+ effector cells .
The levels of radiation used herein may affect both the integrity of the
microvasculature (27) and severely deplete the numbers of circulating platelets
(28) . It was therefore possible that the specific vascular damage caused by the
MBP-reactive cells was accentuated by the absence of effective clotting mecha-
nisms (no platelets), and by the presence of already irradiation-damaged micro-
vasculature, the net result being the extravasation of erythrocytes into the
parenchyma .
To test this hypothesis, rats were depleted of circulating leukocytes with two
cytotoxic drugs and then injected with MBP-stimulated splenocytes (for details
see Materials and Methods) . Drug-treated animals receiving cells developed both
clinical signs of EAE 5-6 d after cell transfer and macroscopic and microscopic
hemorrhage in the spinal cord (Fig. 3a) . Drug treatment alone resulted in neither
clinical signs nor hemorrhage (Fig . 3 b) . The severity of the clinical disease was
not as marked as that seen in either irradiated or nonirradiated recipient animals
receiving equivalent numbers of MBP-stimulated splenocytes, nor was the hem-
orrhage as extensive as that occurring in irradiated animals . This may possibly
reflect killing of some of the injected cells by low levels of cytotoxic drugs still
present in the recipient animal at the time of cell transfer. Nevertheless, clinicalTABLE III
Absence of a Classic DTHReaction in Irradiated RecipientAnimals
SEDGWICK ET AL .
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Irradiated or nonirradiated animals received MBP- or OVA-reactive cells then were ear tested for
DTH responsiveness as described in Materialsand Methods . Some animals from each group were
subsequently sampled for histological examination (Fig. 4) while the remainder were observed for
thedevelopment of clinical signs ofEAE.
* Mean ear thickness (test antigen) - mean ear thickness (control antigen) .
$ Mean ear thickness t 1 SD .
EAE (at least a limp tail and usually also, hind limb weakness) and hemorrhage
in the spinal cord were seen in all recipients of MBP-reactive cells, but never in
those animals treated with drugs alone . Analysis of infiltrating cells in the spinal
cord of drug-treated, recipient rats revealed a similar picture to that seen in
irradiated animals (Table I), but with even fewer leukocytes detected . Numbers
of cells counted in a cross-sectional area of0.13 mm' (as per Table I) in two rats
receiving drugs and MBP-reactive cells were : class II-positive, three and four ;
L-CA', six and nine; pan T-positive, two and one; CD4', four and five ; CD8+ ,
one and two; IL-2-R', one and two ; OX-42'x, seven and seven .
Transfer ofDTH Responsiveness with MBP- and OVA-Reactive Cells.
￿
EAE is
generally considered to be the clinical manifestation ofa DTH reaction in the
CNS (see Introduction) ; however, it is also recognized that it is not possible to
passively transfer DTH reactions into irradiated recipient animals (29) . DTH
responsiveness in such animals is dependent on hematopoietic stem cell replace-
ment, indicating a requirement for host leukocytes in this reaction (29) .
To assess whether the induction of DTH in recipient animals of OVA- and
MBP-reactive cells was dependent on the presence of host leukocytes (and thus
different from passively transferred EAE), in vitro-stimulated cells were trans-
ferred to irradiated or nonirradiated animals and DTH responsiveness in the
ears of recipient rats was tested . Ear swellings were then measured (Table III)
and ears were assessed histologically (Fig. 4) for evidence of a classic DTH
reaction .
In nonirradiated recipient animals (Table 111, groups B and D), DTH was
transferred by both MBP- and OVA-reactive splenocytes and the reaction was
antigen specific . The degree of specific swelling with the two antigens was
virtually identical . Histological examination revealed the presence of a consid-
erable leukocyte infiltrate in the ear that received the antigen to which the
Group Treatment of recipient
Num-
ber of
am-
mals
Ear injected with:
MBP OVA
Change
in ear
thick-
ness*
Histology
MM mm mm
A Irradiated plus MBP ac- 10 0.65 ± 0.02$ 0.56 f 0.06 0.09 Fig . 4 a
tivated cells
B No irradiation plus MBP 9 0.99 ± 0.09 0.59 t 0.06 0.40 Fig. 4, cand e
activated cells
C Irradiated plus OVAac- 5 0.59 t 0.01 0.63 f 0.07 0.04 Fig. 4 b
tivated cells
D No irradiation plus 5 0.61 t 0.01 1.0± 0.1 0.39 Fig. 4, dandf
OVAactivated cells1068
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FIGURE 4.
￿
Histological evidence of absence of a classic DTH reaction in irradiated recipient
animals . Ear swelling in animals treated as per Table III was determined 24 h after injection
of either MBP or OVA into the ears . Representative animals from each group were then
sampled for histological examination of the ears . Shown are paraffin sections stained with H
and E (X 100) of. (a) MBP-injected ear from irradiated recipient of MBP reactive cells; (b)
OVA-injected ear from irradiated recipient of OVA-reactive cells ; (c) MBP- . and (e) OVA-
injected ear from nonirradiated recipients of MBP-reactive cells ; (d) OVA- and (f) MBP-
injected earfrom nonirradiated recipients of OVA-reactive cells.
transferred cells were preactivated (Fig . 4, c and d), but not in the contralateral
ear which was injected with control antigen (Fig . 4, e andf) . Infiltrating cells
were by no means completely absent in the control ears, however (Fig . 4, e and
f), suggesting some level of nonspecificity. MBP in particular appeared to causeSEDGWICK ET AL .
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a mild inflammatory reaction even in normal (nonirradiated, non-cell recipient)
animals, which may indicate the presence of some form of irritant in our MBP
preparation . The extent of this nonspecific inflammation was variable and never
greater than that in Fig. 4f . However, the degree of ear swelling in irradiated
animals was markedly reduced in comparison, and in recipients of either MBP-
or OVA-reactive cells, was not significantly above that seen in the contralateral
ear receiving control antigen (Table III, groups Aand C) . Leukocyte infiltrate
in these animals was considerably less than that seen in non-irradiated rats
(compare Fig . 4, a and c with b and d) .
Particularly interesting was the observation that all recipients of MBP-reactive
cells developed some (albeit mild) clinical signs of EAE 3-4 d after ear testing,
irrespective of the development of DTH in the antigen-challenged ears . Fur-
thermore, hemorrhage was seen in the spinal cord of irradiated recipient rats
but not in the MBP-injected ears of these same animals .
Discussion
The demonstration of the essential role that CD4' T cells play in the induction
of EAE in rats and mice (see also references 5-8) has not shown whether these
cells act alone or in collaboration with other infiltrating cells to cause the nerve
conduction defects characteristic of this disease .
Lethal irradiation of recipient animals of MBP-reactive cells (Table I and Fig .
2) has provided the most direct evidence that the great majority of leukocytes
found in theCNS ofnormal (nonirradiated) rats with EAE play no essential role
in the pathogenesis of this disease . Few infiltrating cells of any type are found in
irradiated recipient rats even though clinical signs of EAE are present. Macro-
phages, which are thought to play some role in demyelinating forms of the
disease induced with whole brain homogenate (9, 30), were present at extremely
low levels in irradiated recipient animals, suggesting that the development of
clinical signs ofEAE in the current model is not dependent on their presence, at
least at the levels normally seen in nonirradiated animals . Similarly, thefrequency
of CD8+ cells was significantly reduced in irradiated rats, suggesting that the
bulk of these cells in nonirradiated animals are not important in pathogenesis .
Furthermore, we have recently shown (Sedgwick, J . D., and D. W. Mason,
manuscript in preparation) that the CD8+ population can be depleted in vivo by
administration ofMRCOX-8 (anti-CD8) mAb and that such animals acquire and
recover from both actively and passively transferred EAE with the same tempo
as rats with a normal compliment of these cells . Given, also, that the only cell
types not reduced in irradiated animals were the infrequent ones expressing the
IL-2-R (Table I and Fig . 2), it is tempting to speculate that it is these cells that
are directly responsible for the transfer of EAE in both irradiated and nonirra-
diated rats, and that thebulk of leukocytes observed in theCNS of nonirradiated
passive EAE recipients are host leukocytes that migrate secondarily to the tissue
damage caused by these IL-2-R+ effector cells . The phenotype of the IL-2-R+
cells is currently being examined by double-staining techniques ; however, given
the demonstration that only anti-CD4 mAbs can prevent EAE in actively (5, 11)
and passively induced EAE in both nonirradiated (5) and irradiated (Table II)
recipient rats, it is highly likely that these cells prove to be CD4+ .1070
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Thesedata provide the first in vivo evidence that (unless cells normally resident
in the CNS play a collaborative role in pathogenesis) it is theCD4+ IL-2-R+ cells
themselves that are the actual mediators of the disease process . What the data
clearly demonstrate is that the CD4+ cells are not simply acting in the capacity
of DTH lymphocytes that attract other leukocytes (e.g., macrophages), which
ultimately are responsible for tissue damage (31) .
Howmay theseCD4+, IL-2-R+T cells alone produce the clinical signs ofEAE?
There is considerable indirect evidence that acute EAE (that form of disease
where clinical signs are relatively short-lived and recovery is spontaneous) is
associated with an increase in vascular permeability in the CNS and that the
transient paralysis observed in this disease is a direct sequel of tissue edema
resulting from this permeability change (32, 33) . Acute relapses in MS may be
associated with a similar phenomenon (34) . The grossly visible hemorrhage seen
in irradiated recipients receiving MBP-reactive cells (Fig . 1) and in those recipi-
ents made leukopenic with cytotoxic drugs (Fig . 3) provides direct evidence that
vascular damage does occur under these circumstances, although to observe such
damage in the form of hemorrhage it is clearly necessary to compromise the
animal's ability to repair the vasculature . In the present case, this was achieved
by reducing platelet numbers with gamma radiation or cytotoxic drugs . The
doses of drugs and irradiation used here have both been shown to reduce platelet
numbers to <20% of normal in the rat (12, 13, 28). Importantly, the induction
of hemorrhage in these rats was highly specific as only MBP- (but not OVA-)
reactive cells were capable of inducing these changes (Fig . 1) . Moreover, the
ability of injected anti-CD4 mAb to not only inhibit EAE in irradiated rats, but
also to prevent hemorrhage (Table 11), confirms that the effector mechanisms
that induced hemorrhage were identical to and representative ofactive EAE and
passive EAE in nonirradiated animals . Thus, it appears that CD4+ cells, possibly
acting in a cytotoxic capacity, may cause damage to the blood vessels within the
CNS, which in turn results in local edema and temporary nerve conduction
defects . Consistent with this hypothesis is the recent demonstration in vitro that
MBP-specific, CD4+ rat T cell lines are cytotoxic and can lyse MBP-presenting
astrocytes (35) and that it is only those lines that induce EAE in vivo that are
also cytotoxic in vitro .
A number of gaps still remain in our understanding of the pathogenesis of this
disease . First, which class II-positive cell population in the CNS is responsible
for stimulating the CD4+ cells in vivo given the absence ofMHC class 11 antigens
in the CNS of rats before EAE induction (36)? Second, if indeed the CD4+
effector cell is cytotoxic for class II-positive targets, what is the target cell(s)? It
is clear, at least in vitro, that CD4+ T cells involved in the induction of EAE
respond only when the antigen is presented by an appropriate class II MHC
antigen-positive accessory cell (7, 8, 37), and there is evidence both in the rat
(8) and the mouse (7) that the actual effector cell responsible for the clinical signs
of disease displays class II MHC antigen restriction . What is evident from the
studies herein, however, is that the majority of the MHC class 11-positive cells
seen in the CNS of nonirradiated rats with EAE are superfluous to disease
induction and that if any such cells are required, then the few remaining in
irradiated rats (Table 1) are obviously sufficient .SEDGWICK ET AL .
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Similarly unresolved is the possible target in vivo of these putative cytotoxic
CD4' T cells. Contrary to observations in the mouse (2) and guinea pig (38),
two thorough studies, including one at the electron microscope level (36, 39),
have clearly shown that even in rats with EAE, MHC class II antigens are
undetectable on the vascular endotheliumandastroglial cells . Thus, even though
CD4' encephalitogenic T cell lines may kill MHC class 11-positive astrocytes in
vitro (35), it is difficult to see how this process operates in vivo . It is worth noting
that the demonstration that the effector cell in rodent EAE is class 11 MHC
antigen restricted (7, 8, 35) is somewhat indirect, as no studies have been made
with MHC recombinant animals . The vasculature of rodent brain expresses class
I MHC antigens constitutively so that no problem with identifying the vascular
endothelium as the target would arise if the final effector cells proved to be
restricted by class I MHC antigens . Effector cells expressing CD4 antigens and
able to recognize and kill MHC class I-positive targets have been described by
others (40, 41) .
In addition to the necessity for an appropriate MHC antigen on the target
cell, antigen (MBP) would also be required for recognition by the MBP-specific
CD4'T cells . Whether this recognition of antigen occurs on the luminal side of
the vasculature due to the presence of MBP bound to the vascular endothelium
(42) or in the parenchyma after nonspecific traffic of activated CD4' T cells
through small blood vessels (43) is not known. Studies are currently in progress
in an attempt to resolve at least some of these issues .
The data presented in Table III and Fig . 4 on the capacity of both OVA- and
MBP-reactive cells to transfer classic DTH reactions (i .e ., that reaction where
there is swelling of the antigen challenge site together with a large leukocyte
infiltrate) to normal (but not irradiated) recipient animals underlines the dissim-
ilarity of this reaction and that which is sufficient to produce clinical signs of
EAE in irradiated rats receiving the same MBP-reactive cells . We have inter-
preted these results as implying that CD4' T cells are the direct mediators of
the disease . Some caution must be exercised in this interpretation, however, as
it is not yet possible to exclude the role of cells normally resident in the CNS
that may collaborate with the MBP-specific CD4' encephalitogenic T cells to
produce tissue damage . Specifically, microglia are thought by some to be the
mononuclear phagocytic cell of the brain and may, for example, secrete IL-I
under appropriate conditions of activation (44) . Furthermore, while these cells
are alsoMHC class 11-negative in normal rats, unlike vascular endothelium and
astroglial cells, activated microglia do express la antigen in animals with EAE
(36, 39) . It is possible, however, that the majority of these Ia+ cells are actually
infiltrating macrophages derived from the bone marrow (45) that appear in
response to damage by the CD4' effector T lymphocytes . Indeed, Ia+ microglia
are not detectable untiljust before the onset of clinical signs of EAE in normal
rats and increase in numbers thereafter (39), so their relevance to the develop-
mental stages of EAE is still in doubt . Moreover, very few Ia+ cells of any sort
are seen in irradiated rats with EAE (Table I), which suggests that large numbers
of these putative la'-activated microglia are not central to disease induction . As
the origins of microglia and even their designated role as brain macrophages are
still areas of some controversy (46), further studies are clearly required to1072
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establish the real function of these cells and whether there is any interaction of
microglia and CD4+ T cells in the inductive phase of EAE in rats and mice.
The relevance of these studies to our understanding of the pathogenesis of
MS is particularly highlighted by recent evidence that suggests that the IL-2-R
(47-49) or other markers of T cell activation (50, 51) may be potentially useful
as indicators of the presence of presumed pathogenic T cells in the CNS and
peripheral blood of MS patients. In humans as well as animals, therefore, it is
clearly necessary to direct our attention toward the elucidations of the mecha-
nisms by which these cells may initiate the disease process.
Summary
One characteristic of experimental allergic encephalomyelitis (EAE) in all
species is the presence of a considerable leukocyte infiltrate in thecentral nervous
system (CNS). By adoptive transfer of EAE into irradiated or nonirradiated
Lewis strain rats we now show that the bulk (>90%) of infiltrating cells in the
CNS are superfluous to the induction of disease, as lethally irradiated recipients,
despite having very few infiltrating cells in the CNS, acquire severe paralytic
EAE. The reduction in the level of infiltration in irradiated recipients is selective,
however, as both irradiated and nonirradiated diseased animals have very similar
numbers of cells expressing IL-2-R. Disease in irradiated recipient animals is
associated with substantial submeningeal hemorrhage in the spinal cord and
brain stem and similar hemorrhages are found in recipients rendered leukopenic
with cytotoxic drugs. Clinical signs of disease and hemorrhage are preventable,
however, by administration to the recipient rats of mAbs specific for the CD4
antigen. Classic delayed-type hypersensitivity (DTH) reactions are transferable
with the same cells that produce EAE in both irradiated and nonirradiated
recipient rats, but such transfer of DTH is observed only in nonirradiated
recipient animals and not in irradiated rats.
Collectively, the findings reported herein support the conclusion that the
paralysis characteristic of acute EAE is mediated by the direct action of very
small numbers of activated CD4' lymphocytes that infiltrate the CNS and
produce their effects by inducing vascular damage. The findings are not consist-
ent with reports that the lesions in EAE are produced by a classic DTH reaction.
Many thanks are extended to A. J. Haven for preparingand cutting cryostat and paraffin
sections, to Stan Buckingham and Catherine Lee for photography, and Caroline Griffin
for typing the manuscript.
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